Rhythm Technologies announced new research emphasizing the clinical and health-economic advantages of its Zio LTCM system.

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Pharmacists who received active feedback about their heart failure patients increased the frequency of their patient interactions and prescribed more heart failure medication adjustments, according to ...

Here we examine some of the concerns for the defense of medical malpractice cases when an issue arises as to the use of a ...